Prognosis of immune checkpoint inhibitors-induced myocarditis: a case series.

Cyrille CoustalJuliette VanoverscheldeXavier QuantinCandice LesageJean-Marie MichotAriane LapparaStephane R EderhyEric AssenatMaxime FaureNahema IssaOlivier LambotteMathieu PuyadeOlivier DereureDiego TosiPatricia RullierIsabelle SerreRomaric LarcherKada KloucheGérald ChanquesHélène Vernhet-KovacsikJean-Luc FaillieAudrey AgulloFrançois RoubillePhilippe GuilpainAlexandre Thibault Jacques Maria

Published in: Journal for immunotherapy of cancer (2023)

The management of ICI-related myocarditis may be challenging and requires a multidisciplinary approach. Prognostic features are herein described and may help to allow ICI rechallenge for some patients with smoldering presentation, after an accurate evaluation of benefit-risk balance.

Keyphrases

high glucose
diabetic rats
high resolution
quality improvement
case report
oxidative stress